JENBURKT PHARMACEUTICAL L Intrinsic Value
JENBURPH · Healthcare · Current price ₹1,045
Is JENBURKT PHARMACEUTICAL L undervalued?
DocStoX estimates the fair value of JENBURKT PHARMACEUTICAL L at ₹1,131 per share, versus the current market price of ₹1,045. That puts the stock about +8.2% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹570), Relative P/E (₹2,387), Graham floor (₹889). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹570 (bear) to ₹1,131 (base) to ₹2,387 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,045 versus an intrinsic value of ₹1,131, JENBURKT PHARMACEUTICAL L currently offers +8.2% of margin.
More on JENBURKT PHARMACEUTICAL L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.